UPDATE 1-Gilead Posts Positive Results in Mid-Stage Hepatitis C Study

Published November 11, 2012

UPDATE 1-Gilead posts positive results in mid-stage Hepatitis C study

Filed under: drug treatment news 2012

(Adds information about another drug combination from a rival). Nov 10 (Reuters) – Gilead Sciences Inc on Saturday reported a 100 percent cure rate u sing a combination of drugs i n a small number of patients with the most common and hardest to treat …
Read more on Reuters

Seattle Genetics' ASH 2012 Presentations Highlight ADCETRIS® and …

Filed under: drug treatment news 2012

ADCETRIS received accelerated approval from the U.S. Food and Drug Administration (FDA) for two indications: (1) the treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant (ASCT) or after failure of at least two …
Read more on DailyFinance

Sanofi draws fire over cost of MS drug Lemtrada

Filed under: drug treatment news 2012

The injectable drug, chemically known as alemtuzumab, was sold until September 2012 under the name Campath as treatment for leukemia and given more frequently at a higher dosage. "There is concern that with a license for multiple sclerosis, the cost of …
Read more on Chicago Tribune